Zan Shen
- Oncology top 2%
- Vascular Tumors and Angiosarcomas 11
- Colorectal Cancer Treatments and Studies 9
- Cancer Research top 5%
- MicroRNA in disease regulation 8
-
- Sarcoma Diagnosis and Treatment 40
- Lung Cancer Treatments and Mutations 15
- Internal Medicine top 5%
-
- Bone Tumor Diagnosis and Treatments 14
-
- Lymphoma Diagnosis and Treatment 9
-
- Management of metastatic bone disease 8
Zan Shen
151 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 122
- Oncology 1.2k
- Cancer Research 632
- Pulmonary and Respiratory Medicine 1.0k
- Internal Medicine 84
- Orthopedics and Sports Medicine 176
Countries citing papers authored by Zan Shen
This map shows the geographic impact of Zan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zan Shen more than expected).
Fields of papers citing papers by Zan Shen
This network shows the impact of papers produced by Zan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zan Shen. The network helps show where Zan Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zan Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 12 | |
| 8 | 2020 | 6 | |
| 9 | Assessment Of Maternity Staff Training And Knowledge Of Obstetric Care In Burkina Faso: A Repeated Cross-Sectional Study | 2019 | 0 |
| 10 | Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma | 2018 | 0 |
| 11 | 2018 | 5 | |
| 12 | Relationship Between HSP70 and ERBB2 Expression in Breast Cancer Cell Lines Regarding Drug Resistance. | 2016 | 8 |
| 13 | 2015 | 6 | |
| 14 | 2013 | 8 | |
| 15 | 2013 | 2 | |
| 16 | 2013 | 28 | |
| 17 | 2012 | 1 | |
| 18 | 2008 | 27 | |
| 19 | 2008 | 14 | |
| 20 | [Our experience in the subject of early gastric cancer]. | 1987 | 1 |
About Zan Shen
Zan Shen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Internal Medicine and Pathology and Forensic Medicine, having authored 155 papers that have together received 3.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (40 papers), Lung Cancer Treatments and Mutations (15 papers), Bone Tumor Diagnosis and Treatments (14 papers), Vascular Tumors and Angiosarcomas (11 papers), Colorectal Cancer Treatments and Studies (9 papers), Lymphoma Diagnosis and Treatment (9 papers), MicroRNA in disease regulation (8 papers) and Management of metastatic bone disease (8 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (632 citations), Pulmonary and Respiratory Medicine (1.0k citations), Internal Medicine (84 citations) and Orthopedics and Sports Medicine (176 citations). Zan Shen has collaborated with scholars based in China, Italy and Hong Kong. Frequent co-authors include Yang Yao, Wei‐Xiang Qi, Lina Tang, Aina He, Yuanjue Sun, Feng Lin, Daliu Min, Wenxi Yu, Shuier Zheng and Yujing Huang. Their work appears in journals such as PLoS ONE, British Journal of Clinical Pharmacology, Current Medical Research and Opinion, Cancer Letters and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.